Tag: vaccine effectiveness

Latest articles

Raja Sharif - Vaccine passports, technology and trust: is the NHS heading in the right direction?

Vaccine passports, technology and trust: is the NHS heading in the right direction?

With news this week that health leaders are making a plea for the government to unleash Plan B or face crisis over the winter...
Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NHS Confederation calls for more measures to avoid a winter crisis

NHS Confederation calls for more measures to avoid a winter crisis

The NHS Confederation is calling for a ‘Plan B plus’ in a plea for the government to introduce measures, such as mandatory face coverings...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
New COVID-19 test reduces testing time from 30 minutes to five

New COVID-19 test reduces testing time from 30 minutes to five

University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
Raja Sharif - Vaccine passports, technology and trust: is the NHS heading in the right direction?

Vaccine passports, technology and trust: is the NHS heading in the right direction?

With news this week that health leaders are making a plea for the government to unleash Plan B or face crisis over the winter...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
MHRA authorises Koselugo for children aged 3 years and above with neurofibromatosis type 1

MHRA authorises Koselugo for children aged 3 years and above with neurofibromatosis type 1

AstraZeneca and MSD’s Koselugo®▼(Selumetinib) has been granted Conditional Marketing Authorisation in Great Britain by the Medicines & Healthcare products Regulatory Agency (MHRA) as monotherapy...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription